NiKem Research ( entered into a research service deal with InterMune ( related to pulmonology. In the next 12 months, NiKem will use its medicinal chemistry and early ADMET/PK platform and expertise to design, synthesize, and profile drug-like compounds aimed toward specific, undisclosed pulmonology targets of interest for InterMune.

Next articleUMMZ Periodical Cicada Page